Kent Emry to Continue as Independent Director Following Planned Leadership Transition ANAHEIM, CA - January 6, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer and ...
The sNDA for AXS-05 for Alzheimer disease agitation includes findings from four phase 3 trials showing improved behaviors and delayed relapse.
Mr. Lucido succeeded Kent Emry, who has served on BioCorRx’s Board of Directors since 2013 and will continue to serve as an independent director, ensuring continuity of leadership and governance.
Woman's World on MSN
Which statin is right for you? Compare meds with this handy intensity chart you'll want to save for future reference
If you have high cholesterol, there's a good chance your doctor has recommended statins to get your numbers back into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback